Reported Standalone quarterly numbers for Astec Lifesciences are:
Net Sales at Rs 91.08 crore in June 2025 up 31.29% from Rs. 69.37 crore in June 2024.
Story continues below Advertisement
Quarterly Net Loss at Rs. 33.06 crore in June 2025 up 16.81% from Rs. 39.74 crore in June 2024.
EBITDA stands negative at Rs. 10.50 crore in June 2025 up 76.84% from Rs. 45.34 crore in June 2024.
Astec Life shares closed at 863.20 on July 25, 2025 (NSE) and has given -11.54% returns over the last 6 months and -31.87% over the last 12 months.
Story continues below Advertisement
| Astec Lifesciences | | Standalone Quarterly Results | in Rs. Cr. |
|
| Jun'25 | Mar'25 | Jun'24 | | Net Sales/Income from operations | 91.08 | 119.53 | 69.37 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 91.08 | 119.53 | 69.37 | | EXPENDITURE | | Consumption of Raw Materials | 59.41 | 85.45 | 33.71 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | 4.48 | -11.92 | 47.88 | | Power & Fuel | -- | -- | -- | | Employees Cost | 15.18 | 14.43 | 16.23 | | Depreciation | 11.51 | 11.59 | 9.28 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 23.00 | 26.04 | 17.80 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -22.49 | -6.07 | -55.53 | | Other Income | 0.49 | 0.78 | 0.91 | | P/L Before Int., Excpt. Items & Tax | -22.01 | -5.29 | -54.62 | | Interest | 11.05 | 10.40 | 7.05 | | P/L Before Exceptional Items & Tax | -33.06 | -15.69 | -61.67 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -33.06 | -15.69 | -61.67 | | Tax | -- | 0.41 | -21.93 | | P/L After Tax from Ordinary Activities | -33.06 | -16.10 | -39.74 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -33.06 | -16.10 | -39.74 | | Equity Share Capital | 19.61 | 19.61 | 19.61 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -16.86 | -8.21 | -20.26 | | Diluted EPS | -16.85 | -8.21 | -20.26 | | EPS After Extra Ordinary | | Basic EPS | -16.86 | -8.21 | -20.26 | | Diluted EPS | -16.85 | -8.21 | -20.26 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
